Rehydration is the mainstay of therapy of E.<unk><unk> . Oral rehydration fluids (e.g. oral rehydration solutions) are indicated among patients who can tolerate oral intake, otherwise IV rehydration is indicated. Since the majority of cases of E.<unk><unk>  are self-limited and the exact infective strain is often not identified, empiric antimicrobial therapy is generally not recommended. Antimicrobial therapy using either fluoroquinolone or TMP-SMX may be administered (but is not required) in ETEC infection (traveler's diarrhea), EPEC infection, and EIEC infection, but not in EHEC infection (due to increased risk of hemolytic uremic syndrome and prolonged shedding). In adults, additional pharmacologic therapies may include antiemetic agents (not recommended in pediatric patients). Antidiarrheal agents are generally not recommended during the acute infection phase.
Escherichia coli enteritis medical therapy
Escherichia coli infection medical therapy
Shigellosis medical therapy
Campylobacteriosis medical therapy
Traveler's diarrhea medical therapy
Brucellosis medical therapy
Norovirus infection medical therapy
Appendicitis medical therapy